At Hawaiian Eye, George B. Bartley, MD, discusses different management options for patients with ptosis.
Uncategorized
Inflammatory factors cause damage to back of eye following keratoprosthesis implantation
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a…
Uncategorized
Lumina accommodating IOL improves near visual acuity, contrast sensitivity
A new accommodating IOL improved visual function, accommodation and contrast sensitivity, according to a study.The study authors compared visual acuity, accommodation and contrast sensitivity with the Lumina accommodating IOL (AkkoLens) vs. a standard …
Uncategorized
Benefactors endow $25 million gift to USC eye institute
Gayle and Edward Roski have endowed a $25 million gift to the University of Southern California’s Keck School of Medicine eye institute, which is to be named the Gayle and Edward Roski Eye Institute, according to a press release. “This gift will enable us to advance eye research in fields such as ocular imaging, drug delivery, dry eye, stem cell therapies, and public health and policy,” Rohit Varma, MD, MPH, professor and chair of the department of ophthalmology and interim dean of the Keck School of Medicine, said in the release. “These funds will also establish a surgical training laboratory for teaching the most advanced surgical skills to the next generation of eye surgeons.”
Uncategorized
Latest developments in endothelial keratoplasty aimed at graftless surgery, regeneration
Endothelial keratoplasty has created a revolutionary paradigm shift in the treatment of corneal endothelial disease. Through several iterations the procedure has become increasingly selective, and further developments are now on the horizon.According t…
Uncategorized
Endothelial keratoplasty continues to evolve toward greater achievements
Endothelial keratoplasty has been one of the most remarkable advances in ophthalmology, rapidly evolving through progressive refinement and widely adopted all over the world. Today in the U.S., Europe and most parts of Asia, 90% of situations in which corneal transplantation is needed and the main problem is the endothelium are dealt with by endothelial keratoplasty techniques rather than full-thickness transplantation. It is particularly in the last 2 or 3 years that initial resistance to this surgery — which was considered a difficult procedure and not within everyone’s reach — has been decisively overcome. Nowadays, only very few corneal surgeons are unable to offer endothelial transplantation to their patients, either because they do not have the expertise or work in hospitals with limited facilities.Endothelial keratoplasty was quickly adopted in the U.S., where Descemet’s stripping automated endothelial keratoplasty became the gold standard. In Europe, where many surgeons were DSAEK-skeptic, the true shift occurred when Descemet’s membrane endothelial keratoplasty entered the scene. Something similar to the U.S. happened in Asia, although more and more surgeons are now converting to DMEK. Although no precise data are available concerning the relative proportion of DSAEK and DMEK, my perception is that DMEK currently accounts for about 25% of the endothelial procedures in the U.S., approximately 50% in Asia and about 60% in Europe. DMEK here has definitely overtaken DSAEK, especially in larger centers, and the majority of high-volume cornea surgeons in Europe are carrying out DMEK.